This article, entitled “QGC606, a best-in-class orally active centrally acting aminopeptidase A inhibitor prodrug, for…
Actualités
Quantum Genomics Reports First Half 2020 Financial Results
Quantum Genomics Reports First Half 2020 Financial Results and Provides Corporate Update Read the press…
Quantum Genomics to give an exclusive license for firibastat in South-East Asia, Australia and New Zealand
Quantum Genomics to give an exclusive license for firibastat in South-East Asia, Australia and New…